Ticker
BIOACompany Name
BIOAGE LABS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 155.23M | $ 387.32M | $ -6M | $ 0 | -245.64% |
3/31/2025 | $ 141.61M | $ 0 | $ 0 | $ 0 | 0% |
12/31/2024 | $ 157.02M | $ 387.74M | $ -6M | $ 0 | -243.11% |
9/30/2024 | $ 739.2M | $ 0 | $ 0 | $ 0 | 0% |
12/31/2023 | $ 0 | $ 4K | $ 34.98M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for BIOAGE LABS INC is calculated as follows: (-1 * CF - Equity [ $ 4K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 34.98M ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.12% |